Vaccinex
A clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases. Learn more
Launch date
Employees
Market cap
AUD15.0m
Enterprise valuation
AUD17m (Public information from Sep 2024)
Share price
$4.55 VCNX
Rochester New York (HQ)
Authorizing premium user...